In a groundbreaking move, President Trump has signed a memorandum urging pharmaceutical companies to adhere to transparency laws in their advertising, especially on social media. This initiative aims to ensure accurate drug information and tackle misleading ads, marking a significant shift in health policy.
In a surprising policy shift, President Trump has directed a ban on TV drug advertising, a move that could reshape the pharmaceutical landscape and impact major networks. Discover the implications of this controversial decision!
In a bold move, President Trump calls for pharmaceutical companies to justify the success of their Covid drugs amid a leadership crisis at the CDC. As the FDA tightens vaccine eligibility, tensions rise over vaccine efficacy and public health transparency.
In a bold move, President Trump is set to sign an executive order mandating the U.S. health department to negotiate lower drug prices with pharmaceutical companies. This could drastically change healthcare costs for millions of Americans.
In a surprising announcement, Trump declares he will sign an executive order to slash prescription drug prices in the U.S. to match those of other high-income countries, potentially reducing costs by 30% to 80%.
In a surprising move, President Trump has nominated Casey Means, a health entrepreneur and advocate for a controversial health agenda, as the new Surgeon General, replacing Janette Nesheiwat amid credential controversies.
As President Trump prepares to unveil a major tariff plan, pharmaceutical companies are lobbying for a gradual implementation to mitigate the impact on drug prices and supply. With potential tariffs looming, how will the industry adapt?
